CVS Health Corporation which can be found using ticker (CVS) now have 24 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between $91.12 and $57.00 with the average target price sitting at $67.31. Now with the previous closing price of $58.17 and the analysts are correct then we can expect a percentage increase in value of 15.7%. The 50 day MA is $59.84 and the 200 moving average now moves to $65.15. The company has a market capitalization of 71.52B. Currently the stock stands at: $56.85 USD
The potential market cap would be $82,753,184,281 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 10.12, revenue per share of $284.37 and a 2.87% return on assets.
CVS Health Corporation, together with its subsidiaries, is a diversified health solutions company. The Company’s segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. Its Health Care Benefits offer a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare supplement plans, and Medicaid health care management services. Its Health Services provides a full range of pharmacy benefit management solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, and diagnostic testing.
